ADA Gene Variant: Attention Span and Lifespan Explained

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on brain & cognitive health. Browse all Brain & Cognitive Health education

Some people wake genuinely refreshed after seven hours; others need nine and still feel foggy. One overlooked reason sits in a single enzyme, adenosine deaminase, and a common variant in its gene. ADA shapes how deeply you sleep, which in turn shapes daytime attention — and, because the same enzyme is essential to your immune system, ADA also has a striking connection to long-term health.

What ADA (adenosine deaminase) does

ADA codes for adenosine deaminase, an enzyme that breaks down adenosine. Adenosine has two jobs worth knowing: it builds up in the brain across your waking hours to create "sleep pressure," and it is a critical molecule in immune-cell metabolism. By regulating adenosine levels, ADA sits at the intersection of how you sleep and how your immune system functions.

The ADA G22A (rs73598374) variant and deep sleep

A common variant, rs73598374 (a G22A change producing an Asp8Asn substitution), lowers ADA enzyme activity. With slower breakdown, adenosine lingers, and carriers of this lower-activity variant have been shown in sleep research to spend more time in deep, slow-wave sleep — the most physically restorative stage. In practical terms, some people are genetically wired to get more restorative sleep per hour than others.

How adenosine ties sleep to attention and focus

Attention is downstream of sleep quality. Slow-wave sleep supports memory consolidation and next-day cognitive performance, so a variant that increases deep sleep can plausibly influence daytime focus and mental stamina. Adenosine also acts directly in brain circuits involved in arousal and attention. This is why researchers studying ADA look at both sleep architecture and cognitive endpoints — the two are biologically linked, not separate.

It is worth keeping the effect in proportion. A genetic tendency toward deeper sleep is a small structural advantage, not a substitute for enough hours in bed. The person with a favorable ADA variant who sleeps five hours will still underperform the person who protects a full night. Genetics can shift the efficiency of your sleep; it does not repeal the need for it, and daytime attention still rests mostly on the basics of duration, consistency, and timing.

ADA, immune function, and the lifespan angle

The lifespan connection is more dramatic at the extreme end. Rare, severe loss-of-function mutations in ADA cause ADA-deficient severe combined immunodeficiency (SCID), a serious inherited immune disorder — direct proof that adenosine deaminase is essential for healthy immune cells. The common rs73598374 variant is not in that category and does not cause immunodeficiency, but it illustrates why a single enzyme touching both sleep and immunity draws interest from researchers studying healthy aging.

Related pathways — adenosine, caffeine, and ADORA2A

ADA does not act alone. The adenosine A2A receptor gene, ADORA2A (variant rs5751876), influences how sensitive you are to caffeine and how much it disrupts your sleep. Someone with a lower-activity ADA variant and a caffeine-sensitive ADORA2A profile has a very different relationship with an afternoon coffee than someone with the opposite pair. These interacting variants are why blanket sleep advice fails so many people.

What pathway-level genetic insight adds

Understanding your adenosine genetics turns vague sleep frustration into something you can work with. The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants in the adenosine and sleep-regulation pathways such as ADA and ADORA2A. It does not diagnose a sleep disorder or predict your lifespan — it gives you pathway-level context so decisions about caffeine timing, sleep scheduling, and when to seek professional help start from your biology.

Frequently Asked Questions

What does the ADA gene variant do?

The ADA gene codes for adenosine deaminase, which breaks down adenosine. The common rs73598374 (G22A) variant lowers enzyme activity, so adenosine lingers longer. Sleep research links this variant to more deep, slow-wave sleep — the most restorative stage — which can influence daytime attention and mental stamina.

Does the ADA variant affect how long I sleep?

It affects sleep quality more than raw duration. Lower-activity ADA variants are associated with a higher proportion of deep, slow-wave sleep, meaning some carriers get more restorative rest per hour. This is a tendency shown across research groups, not a guarantee about any single person's sleep needs.

Is the ADA variant related to immune problems or lifespan?

The common rs73598374 variant does not cause immune disease. Only rare, severe ADA mutations cause ADA-deficient SCID, a serious immunodeficiency. The common variant simply shows why one enzyme linking sleep and immune metabolism interests aging researchers. It is educational context, not a diagnosis or a lifespan prediction.

Genetics as a guide, not a guarantee. If you want to understand your own peptide-related pathways at the DNA level before your next conversation with a provider, the Precision Peptide Genetic Test maps the variants that shape your baseline biology — so you can test before you invest.

This article is part of the PlexusDx Education Hub. Browse all Brain & Cognitive Health education

Disclaimer: The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.